Wantstats
Healthcare

Adalimumab Biosimilar Market

By Segment, By Region, And Segment Forecasts, 2017 – 2027

Vertical: HealthcareBase Year: 201912 Sections

Book DemoPurchase Report

Executive Summary

Adalimumab Biosimilar Market — Snapshot

  • Market Size (2017)

    2017

    —

  • Projected (2027)

    2027

    —

  • CAGR (2017–2027)

    N/A

  • Key Players

    107+

1.1. Market Attractiveness Analysis

1.1.1. Global Vagal Nerve Stimulation Market, by Products

1.1.2. Global Vagal Nerve Stimulation Market, by Application

1.1.3. Global Vagal Nerve Stimulation Market, by End User

1.1.4. Global Vagal Nerve Stimulation Market, by Region

Global vagal nerve stimulation market is expected to grow at 8.3% CAGR during the forecast period, 2020-2027.

TABLE 1 Market synopsis

Market Size

· 2019: USD XXXX Million (Approx.)

· 2027: USD XXXX Million (Approx.)

CAGR (2020–2027)

· 8.3% (Approx.)

Key Market Drivers

· Increasing prevalence of neurological disorders

· Increasing investment of biotechnology and pharmaceutical industries in R&D

Key Market Opportunities

· XXXXXXXXXXXXX

Key Vendors

· LivaNova PLC

· EnteroMedics Inc

· ElectroCore Medical LLC

· Boston Scientific Corporation

· Cyberonics, Inc

· NeuroMetrix, Inc

· ImThera Medical

· Inspire Medical Systems, Inc

· Parasym Ltd

· Innovative Health Solutions INC

· Others

1.1 market attractiveness analysis

1.1.1 Global VAGAL NERVE STIMULATION MARKET, by PRODUCTS, 2019 (%)

FIGURE 1 Global VAGAL NERVE STIMULATION MARKET, by PRODUCTS, 2019 & 2027 (USD Million)

1.1.1 Global VAGAL NERVE STIMULATION MARKET, By APPLICATION

FIGURE 1 Global VAGAL NERVE STIMULATION MARKET, by APPLICATION, 2019 (%)

FIGURE 1 Global VAGAL NERVE STIMULATION MARKET, APPLICATION2019 & 2027 (USD Million)

1.1.1 Global VAGAL NERVE STIMULATION MARKET, By END USER

FIGURE 1 Global VAGAL NERVE STIMULATION MARKET, by END USER, 2019 (%)

FIGURE 1 Global VAGAL NERVE STIMULATION MARKET, END USER, 2019 & 2027 (USD Million)

Key Insight

Adalimumab Biosimilar Market is a key focus area for market intelligence and strategic research.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 4 regions: North America, Europe, Asia Pacific, Rest of the World.
  • Market Segmentation: The market is analyzed across key segments with forecasts from 2017 to 2027.
  • Competitive Landscape: 107 leading companies are profiled, covering market positioning, strategies, and recent developments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Adalimumab Biosimilar Market — Growth Trajectory

Vagal nerve stimulation or vagus nerve stimulation (VNS) is a treatment method that involves delivering electrical impulses to the vagus nerve. Vegas nerve acts as a translator between gut and brain. Gut uses the vagus nerve like a walkie-talkie and translates signals via electric impulses, which called action potentials. VNS treatment is used for certain types of intractable epilepsy, depression, and others. In most common cases, overstimulation of the vagus nerve causes fainting. Vagus nerve stimulation is a procedure, which involves implantation of a device that stimulates the vagus nerve with electrical impulses.

Market Share by Application

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • PRODUCTS PRODUCTS is broken down into: Implantable VNS devices, External VNS devices.
  • APPLICATION APPLICATION is broken down into: Depression, Epilepsy, Others.
  • END USER END USER is broken down into: Hospitals, AmbulatorySsurgical Centers, END USER_Others.

Geographic Analysis

Regional market breakdown

  • North America North America is one of the key regions covered in this market analysis.
  • Europe Europe is one of the key regions covered in this market analysis.
  • Asia Pacific Asia Pacific is one of the key regions covered in this market analysis.
  • Rest of the World Rest of the World is one of the key regions covered in this market analysis.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Adalimumab Biosimilar Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2019

  • Historical Period

    2017 – 2019

  • Forecast Period

    2019 – 2027

  • Primary Interviews

    150+

Research Process

Historical data (2017–2019) and forecast period (2019–2027)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now
Book a demo

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Adalimumab Biosimilar Market — Key Findings

Analytical insights on Adalimumab Biosimilar Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

Adalimumab Biosimilar Market represents a significant market opportunity with multiple growth drivers across regions and segments.

Market Dynamics

The Adalimumab Biosimilar Market market encompasses 4 key regions and multiple market segments, with the study period spanning 2017 to 2027.

The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.

Competitive Landscape

This report profiles 107 key companies operating in the Adalimumab Biosimilar Market market, covering market positioning, product portfolios, and recent developments.

Leading players include LivaNova PLC, EnteroMedics Inc, ElectroCore Medical LLC, Boston Scientific Corporation, Cyberonics, Inc, and 102 others.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Companies

Key companies profiled in Adalimumab Biosimilar Market

Profiles of 107 companies operating in the Adalimumab Biosimilar Market market, including revenue, employee count, and market positioning where available.

Showing 107 of 107 companies

LivaNova P

LivaNova PLC

Healthcare

Company Headquarters: London, UK Founded: 2015 Workforce: 4,500 employees Company Working: The company is engaged in developing and delivering advanced medical devices for healthcare systems. The company operates in two segments, namely, cardiac surgery and neuromodulation. The company offers VNS Therapy in the brain implants market. The company has a presence in more than 100 countries.

Revenue$0.4B
Employees4,500
Market CapN/A
Founded2014
London, UK
Boston Sci

Boston Scientific Corporation

Healthcare

Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.

Revenue$8.4B
Employees36,000
Market CapN/A
Founded1978
Massachusetts, US
Innovative

Innovative Health Solutions INC

Healthcare

Innovative Health Solutions INC — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Parasym Lt

Parasym Ltd

Healthcare

Parasym Ltd — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
ImThera Me

ImThera Medical

Healthcare

ImThera Medical — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
ElectroCor

ElectroCore Medical LLC

Healthcare

ElectroCore Medical LLC — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Page 1 of 18
…
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all
RF Microneedling Market

RF Microneedling Market

Europe Ostomy Care Market

Europe Ostomy Care Market

Functional Service Providers Market

Functional Service Providers Market

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Adalimumab Biosimilar Market

Starting from
$4,950